Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RPRX > SEC Filings for RPRX > Form 8-K on 21-Jan-2014All Recent SEC Filings

Show all filings for REPROS THERAPEUTICS INC.



Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 16, 2014, the Compensation Committee of the Board of Directors of Repros Therapeutics Inc. (the "Company") approved a grant to Katherine Anderson, the Company's Chief Financial Officer, of options to purchase 5,000 shares of the Company's common stock, $0.001 per share (the "Common Stock"), as compensation for her work in 2013. The options, which were granted under the Company's 2011 Equity Incentive Plan, have a per share exercise price of $21.48, the closing price of the Common Stock on the Nasdaq Stock Market on the date of grant, a term of 10 years, and will vest in quarterly installments over the three years following the date of grant.

  Add RPRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RPRX - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.